Dheeraj Kumar Lohia sold 1,759 shares of Jeevan Scientific Technology Limited, reducing his stake from 2.65% to 2.62% and leaving him with 5,26,393 shares.
An independent clinical contract research organization providing technology-driven solutions for clinical trials and healthcare research. Incorporated in 1999, the company specializes in comprehensive research services to pharmaceutical, biotechnology, and medical device sectors across India. Its distinctive approach combines advanced analytics capabilities with clinical expertise and regulatory knowledge to support drug development and compliance requirements for both domestic and international clients seeking research partnerships.
Known in small-cap circles for buying Shivalik Bimetals around ₹30 and holding through a 20x move, the kind of call that builds a reputation. Dheeraj Kumar Lohia operates through Dheeraj Kumar Lohia and Associates, running a ~₹228 Cr portfolio across 60+ stocks in industrials, pharma, and specialty niches. An early mover who consistently shows up in filings before the crowd arrives.
